Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2006 Sep;55(9):1341-9.
doi: 10.1136/gut.2006.093484.

PPARgamma as a new therapeutic target in inflammatory bowel diseases

L Dubuquoy  1 , C Rousseaux, X Thuru, L Peyrin-Biroulet, O Romano, P Chavatte, M Chamaillard, P Desreumaux
Affiliations
Review

PPARgamma as a new therapeutic target in inflammatory bowel diseases

L Dubuquoy et al. Gut. 2006 Sep.

Abstract

The peroxisome proliferator activated receptor gamma(PPARgamma) is a nuclear receptor highly expressed in the colon and playing a key role in bacterial induced inflammation. Regulation of colon inflammation by this receptor has been well demonstrated in many experimental models of colitis but also in patients with ulcerative colitis, characterised by impaired expression of PPARgamma confined to their colon epithelial cells. Recent data showing that PPARgamma was the major functional receptor mediating the common aminosalicylate activities in inflammatory bowel diseases (IBD) have also reinforced the roles of this receptor in the control of intestinal inflammation. The aims of this review are to discuss the potential roles of PPARgamma in the physiopathology of IBD, as well as the emerging therapeutic strategies targeting this receptor.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest: None declared.

References

    1. Hugot J P, Chamaillard M, Zouali H.et al Association of NOD2 leucine‐rich repeat variants with susceptibility to Crohn's disease. Nature 2001411599–603. - PubMed
    1. Ogura Y, Bonen D K, Inohara N.et al A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature 2001411603–606. - PubMed
    1. McGovern D P, Hysi P, Ahmad T.et al Association between a complex insertion/deletion polymorphism in NOD1 (CARD4) and susceptibility to inflammatory bowel disease. Hum Mol Genet 2005141245–1250. - PubMed
    1. Zhu Y, Alvares K, Huang Q.et al Cloning of a new member of the peroxisome proliferator‐activated receptor gene family from mouse liver. J Biol Chem 199326826817–26820. - PubMed
    1. Lehmann J M, Moore L B, Smith‐Oliver T A.et al An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator‐activated receptor gamma (PPAR gamma). J Biol Chem 199527012953–12956. - PubMed

MeSH terms